BRIEF-Onspel公布2018年第四季度和全年财务业绩

March 7 (Reuters) - OncoMed Pharmaceuticals Inc :

   * ONCOMED ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS

   * Q4 LOSS PER SHARE $0.12

   * Q4 REVENUE $10.2 MILLION VERSUS $20.6 MILLION

   * CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED $57.3 MILLION AS OF DECEMBER 31, 2018

Source text for Eikon:  Further company coverage:

((Briefs@thomsonreuters.com;)